Vericel Corp — Director's Dealing 2010

Aug 31, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AASTROM BIOSCIENCES INC (ASTM)
CIK: 0000887359
Period of Report: 2010-08-30

Reporting Person: MAYLEBEN TIMOTHY M (Director, CEO and President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-08-30	Common Stock	P	17200	$1.45	Acquired	69618	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.4425 to $1.45, inclusive. The reporting person undertakes to provide Aastrom Biosciences, Inc., any security holder of Aastrom Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).